Intraocular pressure derailment, hyphema and uveitis in chronic lymphocytic leukemia with ibrutinib therapy

被引：0
|
作者：
Assaf, Abdelrahman [1 ]
Aghayeva, Fidan [2 ]
Lanzl, Ines M. [3 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, Munich, Germany
[2] Chiemsee Augentagesklin, Prien Am Chiemsee, Germany
[3] Tech Univ Munich, Klin & Poliklin Augenheilkunde, Klinikum rechts Isar, Munich, Germany
来源：
OPHTHALMOLOGIE | 2025年
关键词：
D O I：
10.1007/s00347-025-02208-8
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Intraocular pressure rise, hyphema and uveitis in chronic lymphocytic leukemia undergoing ibrutinib treatment
    Assaf, Abdelrahman
    Aghayeva, Fidan
    Lanzl, Ines M.
    OPHTHALMOLOGIE, 2025,
  • [2] Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia
    Mehraban Far, Parsa
    Rullo, Jacob
    Farmer, James
    Urton, Todd
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (04) : 1005 - 1008
  • [3] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2425 - 2437
  • [4] Ibrutinib for Chronic Lymphocytic Leukemia
    Sharman, Jeff P.
    Mato, Anthony R.
    Keating, Michael J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1592 - 1593
  • [5] Chronic lymphocytic Leukemia Ibrutinib was superior to Chlorambucil as Initial Therapy
    Homrich, Mirka
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (05) : 309 - 309
  • [6] Invasive Aspergillosis Related To Ibrutinib Therapy For Chronic Lymphocytic Leukemia
    Arthurs, B.
    Hsu, M.
    Dobos, N.
    Grochowski, C.
    Kim, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Invasive Aspergillosis in the Setting of Ibrutinib Therapy for Chronic Lymphocytic Leukemia
    Oliver, T.
    Cronin, J.
    Sobuto, A. L.
    Sobuto, J. J.
    Peterson, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
    Voshtina, Ensi
    Huang, Huiya
    Raj, Renju
    Atallah, Ehab
    CASE REPORTS IN HEMATOLOGY, 2018, 2018
  • [9] EXPERIENCE OF IBRUTINIB THERAPY IN THE TREATMENT OF PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kurkina, N. V.
    Repina, E. A.
    Mashnina, N. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (01): : 55 - 56
  • [10] Ibrutinib for treatment of chronic lymphocytic leukemia
    Vela, Cory M.
    McBride, Ali
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 367 - 375
12345